Aclaris Therapeutics, Inc. (ACRS)
Market Open
11 Sep, 14:03
$
5. 41
-0.09
-1.7257%
$
861.72M Market Cap
- P/E Ratio
- Div Yield
293,272 Volume
-1.64 Eps
$ 5.5
Previous Close 
Want to track ACRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aclaris Therapeutics, Inc. (ACRS) Statistics
Valuation metrics
Market Cap 861.72M
Enterprise value 842.56M
Trailing P/E (ttm) -10.64
Forward P/E -5.73
PEG ratio -0.23
Price/Sales (ttm) 104.85
Price/Book (mrq) 7.07
Enterprise Value/Revenue 102.51
Enterprise Value/EBITDA -11.22
Overview
Shares outstanding 120.5M
Float 83.07M
Shares short 7.02M
% Held by insiders 0.03%
% Held by institutions 0.84%
Average volume (10 days) 1.64M
Average volume (90 days) 2.13M
Price summary
52-Week low 1.74
52-Week high 6.6
Beta 0.68
50-Day moving average 5.44
200-Day moving average 4.17
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -9.21%
Operating margin -10.5%
Operational effectiveness
Return on assets -0.42%
Return on equity -0.62%
Income Statement
Revenue (ttm) 7.83M
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -0.86%
Gross profit (ttm) -52.1M
EBITDA -74.03M
Net income to common (ttm) -64.92M
Diluted EPS (ttm) -0.53
Quarterly earnings growth (yoy) -0.86%
Balance Sheet
Total cash (mrq) 90.75M
Total cash per share (mrq) 0.64
Total debt (mrq) 2.12M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.46%
Book value per share (mrq) 0.87
Cash Flow
Cash flow statement -47.11M
Levered free cash flow (LFCF) -30.63M
